US House Moves to Block New Reviews of Fetal Tissue Research

An amendment to the 2020 funding bill would prohibit the Trump administration from convening ethics advisory boards to review funding proposals involving the tissues.

Written byShawna Williams
| 1 min read
the US capitol building

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: PIXABAY, BONES64

In the wake of an announcement last week that research using fetal tissue at the National Institutes of Health will halt, and that other federally funded research using the tissue will now require review by ethics advisory boards, the US House voted today (June 13) to include an amendment in the 2020 federal budget that would prevent such boards from being formed.

The amendment passed the Democrat-led House of Representatives in a 225 to 193 vote, Science reports. But it is not clear whether it will become law, as the House will need to agree with the Republican-led Senate on a final spending bill, which would then need to be signed by President Donald Trump in order to take effect. No House Republicans voted for the amendment.

In a letter sent yesterday to lawmakers who support the amendment, a group of research universities, patient advocacy organizations, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies